Experts chart research agenda to fight drug-resistant TBApril 23rd, 2008 - 1:52 pm ICT by admin
Washington, April 23 (ANI): While domestic and international efforts to control the spread of drug-resistant tuberculosis have started to bear fruit, the National Institute of Allergy and Infectious Diseases (NIAID) has formulated a biomedical research agenda for preventing the further emergence of multi-drug-resistant (MDR) and extensively drug-resistant (XDR) forms of the disease.
The TB diagnostic tools in use today are antiquated, slow and insensitive; TB drug regimens are complex and lengthy; and the only vaccine available does not provide effective protection against adult pulmonary TB, says NIAID Director Anthony S. Fauci.
The challenge of TB control is further compounded by the rise of drug-resistant TB, and we anticipate that the NIAID Research Agenda for Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis will contribute substantively to the fight against this emerging threat, adds Dr. Fauci.
The list of research priorities, appearing online in The Journal of Infectious Diseases, calls for the development and testing of reliable technologies to rapidly diagnose TB, and to identify drug resistance.
The NIAID also calls for defining what is the most effective use of the existing TB therapies and other antibiotics available to treat the drug-resistant forms of the disease.
It stresses the need for developing new medicines, particularly to treat MDR and XDR TB.
The organisation says that gaining a deeper understanding of the basic biology of TB-causing bacteria, and their interaction with the human host that underlie the development of drug-resistant TB is the need of the hour.
It also stressed the need for a better understanding of the epidemiology of drug-resistant TB.
Various manifestations of TB in adults, children, and people with co-infections like HIV/AIDS need be investigated, says the report.
The report also calls for increasing research efforts to develop new vaccines and other preventive strategies.
Only a concerted global effort can counteract the rise of drug-resistant TB. Development of improved diagnostics and better treatment and control strategies will depend on collaboration with our partners at every research step, from basic science to large clinical trials, says Dr. Fauci. (ANI)
- Central team to probe drug resistant TB cases in Mumbai - Jan 17, 2012
- Berlin 2010: TB, HIV and Lung Health: From research and innovation to solutions - Nov 02, 2010
- New test top diagnoseTB proves effective, convenient - Sep 02, 2010
- 'Time to scale up work on TB control' - Jan 24, 2012
- WHO calls for dealing with multi-drug resistant microbes - Apr 07, 2011
- China reports 900,000 TB cases in 2011 - Mar 21, 2012
- Government to rope in chemists to fight TB (March 24 is World Tuberculosis Day) - Mar 24, 2012
- Symposium shows progress in TB vaccines - Jun 08, 2010
- TB causing half million annual deaths in South-East Asia: WHO - Mar 22, 2012
- A childhood free from tuberculosis (TB) - Jul 17, 2010
- New hope in fight against HIV, TB - May 21, 2010
- 36 mln people with TB cured, eight mln lives saved since 1995 - Dec 09, 2009
- Gonorrhea cure gets tough as bug grows drug resistant - Nov 08, 2011
- 'Urgent measures needed to control drug resistant TB' - Mar 23, 2012
- Standard re-treatment regimen for TB 'failing' in developing world - Mar 16, 2011
Tags: director anthony, drug regimens, drug resistance, drug resistant tb, drug resistant tuberculosis, hiv aids, human host, increasing research, infectious diseases, international efforts, journal of infectious diseases, national institute of allergy and infectious diseases, new medicines, niaid research, pulmonary tb, reliable technologies, research agenda, research priorities, tb control, xdr tb